Download presentation
Presentation is loading. Please wait.
1
Considerations in Lower Extremity Wounds
Philip McKinney, DPM 11/7/2018
2
Nothing to Disclose 11/7/2018
3
Primary Consideration in LE Wounds
Peripheral neuropathy affecting the lower extremity becomes our primary deterrent to wound healing. Without tactile sensation there is no perception, without perception there is no pain. Pain is God’s greatest gift to mankind. Paul Brand, MD 11/7/2018
4
Paul Wilson Brand, MD (1914-2003)
Began his work at the National Hansen’s Disease Center in Carville, Louisiana in A pioneer in surgery to reconstruct deformities of the hand and feet brought about by Hansen’s disease. It was his initial work in India that provided him with the understanding of the need to address the lack of pain in preventing the wounds from healing. 11/7/2018
5
11/7/2018
6
Cost-effectiveness Studies
11/7/2018
7
Risk Factors for Ulceration
Neuropathy Sensory Motor Autonomic Deformity ( hammertoes, Bunion, Charcot ) Minor Trauma High plantar pressures Shoe pressure High impact Improper foot care Thermal injury Hot soaks Frostbite Limited Joint Mobility ( hallux limitus, equinus) Vascular Disease Macrovascular Microvascular Previous Ulceration Amputation Nephropathy Smoking Hyperglycemia 11/7/2018
8
11/7/2018
9
11/7/2018
10
11/7/2018
11
11/7/2018
12
11/7/2018
13
11/7/2018
14
11/7/2018
15
11/7/2018
16
11/7/2018
17
11/7/2018
18
11/7/2018
19
11/7/2018
20
11/7/2018
21
11/7/2018
22
11/7/2018
23
11/7/2018
24
11/7/2018
25
11/7/2018
26
11/7/2018
27
Equinus 11/7/2018
28
11/7/2018
29
Metatarsal head loading
11/7/2018
30
11/7/2018
31
Pressure plate loading with orthotic use.
11/7/2018
32
Peak Pressure Reduction
11/7/2018
33
Percentage/Days to healing
11/7/2018
34
11/7/2018
35
Charcot foot 11/7/2018
36
11/7/2018
37
Stairway to amputation
11/7/2018
38
Off loading 11/7/2018
39
11/7/2018
40
11/7/2018
41
11/7/2018
42
11/7/2018
43
Wound Assessment Wound description ( color, slough, necrotic tissue)
Wound dimensions ( size, area, depth) Probe for depth Bone, sinus tracts Determine presence of infection Culture as indicated Assess for neuropathy Monofilament, vibration, two point discrimination Vascularity Pulses, rubor, temperature Noninvasive tests ABI, Doppler, TcPO2 Angiography Determine etiology Classification Wagner University of Texas 11/7/2018
44
Wagner Classification of Diabetic Foot Ulcers
Grade 0: No ulcer in a high risk foot. Grade 1: Superficial ulcer involving the full skin thickness but not underlying tissues. Grade 2: Deep ulcer, penetrating down to ligaments and muscle, but no bone involvement or abscess formation. Grade 3: Deep ulcer with cellulitis or abscess formation, often with osteomyelitis. Grade 4: Localized gangrene. Grade 5: Extensive gangrene involving the whole foot. 11/7/2018
45
University of Texas Wound Classification System
Grade I-A: non-infected, non-ischemic superficial ulceration Grade I-B: infected, non-ischemic superficial ulceration Grade I-C: ischemic, non-infected superficial ulceration Grade I-D: ischemic and infected superficial ulceration Grade II-A: non-infected, non-ischemic ulcer that penetrates to capsule or bone Grade II-B: infected, non-ischemic ulcer that penetrates to capsule or bone Grade II-C: ischemic, non-infected ulcer that penetrates to capsule or bone Grade II-D: ischemic and infected ulcer that penetrates to capsule or bone Grade III-A: non-infected, non-ischemic ulcer that penetrates to bone or a deep abscess Grade III-B: infected, non-ischemic ulcer that penetrates to bone or a deep abscess Grade III-C: ischemic, non-infected ulcer that penetrates to bone or a deep abscess Grade III-D: ischemic and infected ulcer that penetrates to bone or a deep abscess 11/7/2018
46
Factors influencing wound closure
Wound Location Tissue extensibility/contracture Depth Size Exudate Bacterial colonization Arterial insufficiency Lymphedema Venous insufficiency Neuropathy Deformity Uncontrolled diabetes Equinus Hypertension Osseous structures Pervious infection Renal insufficiency Malnutrition Anemia Congestive Heart Tobacco Coronary artery disease Alcohol Obesity Drug use Compliance Functional status 11/7/2018
47
11/7/2018
48
11/7/2018
49
11/7/2018
50
11/7/2018
51
Evaluation of Shoes 11/7/2018
52
11/7/2018
53
11/7/2018
Similar presentations
